<DOC>
	<DOCNO>NCT00191815</DOCNO>
	<brief_summary>The purpose study determine objective tumor response first-line therapy combination gemcitabine cisplatin patient metastatic breast cancer</brief_summary>
	<brief_title>Combination Chemotherapy Metastatic Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>You female age 18 75 year old . You diagnose metastatic breast cancer . You desire opportunity visit doctor medical site , realization active treatment program , within 24 month medical follow . You must sign informed consent form You pregnant breastfeed . Your laboratory parameter fall outside limit , admit requirement present clinical study . You diagnose serious concomitant acute infectious disease . You use experimental medication within last month .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>